Akers Bio signs 3-year distribution deal with Diagnostica Stago

Akers Biosciences Inc. has entered into a three-year national distribution agreement for its flagship product with Diagnostica Stago Inc. Under the three-year deal, Stago will distribute South Jersey-based Akers PIFA PLUSS PF4 Rapid Assay, a single-use test for Heparin-induced thrombocytopenia to its customer base of hospital laboratories across the United States. Heparin-induced thrombocytopenia (HIT) is a clinical syndrome that r everses heparin's intended blood-thinning therapeutic effect and…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news